
Results
2
2 companies
PharmaEssentia
Market Cap: NT$239.8b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$646.00
7D
2.2%
1Y
44.8%
Caliway Biopharmaceuticals
Market Cap: NT$173.9b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$112.00
7D
16.9%
1Y
88.6%